On Wednesday, GE HealthCare (NYSE:GEHC) reported second-quarter 2025 adjusted earnings of $1.06 per share, which beat the consensus of 92 cents. It was up from $1.00 a year ago.
The company reported sales of $5.01 billion, beating the consensus of $4.96 billion.
Revenues increased 3% on reported and 2% on an organic basis year-over-year. Revenue growth was driven by strength in the U.S. and Europe, the Middle East, and Africa.
Total company book-to-bill was 1.07 times. Total company orders increased 3% organically year-over-year.
The net income margin was 9.7% versus 8.9% for the prior year, which was up 80 basis points …